AEON Biopharma
AEON
AEON
59 hedge funds and large institutions have $172M invested in AEON Biopharma in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+12
Holders Change %
+25.53%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
7
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$13.6M |
2 |
HSBC Holdings
London,
United Kingdom
|
+$8.77M |
3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$7.89M |
4 |
Citadel Advisors
Miami,
Florida
|
+$4.88M |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
+$3.43M |